| Structure | Chemical Name | CAS | MF |
|
(1R,2R)-2-(4-Fluoro-phenyl)-cyclopropanecarboxylic acid
|
161711-27-9
|
C10H9FO2
|
|
3,4-Difluorohydrocinnamic acid
|
161712-75-0
|
C9H8F2O2
|
|
5,6-Difluoroindanone
|
161712-77-2
|
C9H6F2O
|
|
1H-Indene,5,6-difluoro-(9CI)
|
161712-78-3
|
C9H6F2
|
|
5,6-Difluoro-1H-inden-2(3H)-one
|
161712-79-4
|
C9H6F2O
|
|
alpha-Glucosyl Hesperidin
|
161713-86-6
|
C34H44O20
|
|
4-Nitrobenzyl(1R,5S,6S)-6-[(R)-1-hydroxyethyl]-1-Methyl-2-[1-(1,3-thiazolin-2-yl)azetidin -3-yl]thio-1-carbapen-2-eM-3-carboxylate
|
161715-20-4
|
C23H26N4O6S2
|
|
Tebipenem
|
161715-21-5
|
C16H21N3O4S2
|
|
Tebipenem pivoxil
|
161715-24-8
|
C22H31N3O6S2
|
|
3-Hydroxy-1-(1,3-thiazolin-2-yl)azetidine
|
161715-27-1
|
C6H10N2OS
|
|
3-Acetylthio-1-(1,3-thiazolin-2-yl)azetidine
|
161715-28-2
|
C8H12N2OS2
|
|
1,2,4-Triazolo[4,3-a]pyrimidin-7(1H)-one, 5-mercapto-
|
161715-52-2
|
C5H4N4OS
|
|
N-methyl-trans-4-Methoxy-cyclohexylamine
|
161715-65-7
|
C8H17NO
|
|
4-propan-2-yloxycyclohexan-1-aMine
|
161715-66-8
|
C9H19NO
|
|
2-(p-chlorophenyl)-1(2h)-phthalazon
|
161716-23-0
|
C14H9ClN2O
|
|
2-(4-Fluorophenyl)-1(2H)-phthalazinone
|
161716-49-0
|
C14H9FN2O
|
|
Bicyclo[2.2.1]heptane, 2,2-difluoro-6-methyl- (9CI)
|
161716-74-1
|
C8H12F2
|
|
Bicyclo[2.2.1]heptane, 2,2-difluoro-5-methyl- (9CI)
|
161716-76-3
|
C8H12F2
|
|
1,3,2-Dioxaphosphorinane, 5-butyl-5-ethyl-2-[2,4,6-tris(1,1-dimethylethyl)phenoxy]-
|
161717-32-4
|
C27H47O3P
|
|
4-(2-Methylpropoxy)-1,3-benzenedicarbonitrile
|
161718-81-6
|
C12H12N2O
|
|
3-cyano-4-isobutoxybenzaMide
|
161718-85-0
|
C12H14N2O2
|
|
2H-Pyrrol-2-one,1,5-dihydro-4-hydroxy-5-methyl-5-(1-methylethyl)-(9CI)
|
161719-91-1
|
C8H13NO2
|
|
2H-Pyrrol-2-one,1,5-dihydro-4-hydroxy-5,5-dimethyl-3-(1-methylethyl)-(9CI)
|
161719-92-2
|
C9H15NO2
|
|
Aminobenzoyl-Arg-Val-Lys-Arg-Gly-Leu-Ala-Tyr(NO2)-Asp
|
161721-77-3
|
C54H84N18O16
|
|
(R,R)-3,4-trans-(N-Boc)-diaminopyrrolidine
|
161723-00-8
|
C14H27N3O4
|
|
5-(4-chlorokphenyl)pentanoic acid
|
161725-12-8
|
C11H13ClO2
|
|
5''-Bromo-2,2':5',2''-terthiophene-5-carboxaldehyde
|
161726-69-8
|
C13H7BrOS3
|
|
4-Chloro-2,2'-bipyridine
|
161727-77-1
|
C10H7ClN2
|
|
6-(n-Butoxy)-2,4-diiodo-3-fluorone
|
161728-47-8
|
C17H14I2O3
|
|
1(2H)-Pyridinepropanoic acid, 4,5,6-trihydroxy-2-methyl- (9CI)
|
161728-63-8
|
C9H13NO5
|
|
Rasagiline mesylate
|
161735-79-1
|
C12H13N.CH4O3S
|
|
(11β,16α)-9-Fluoro-11,21,21-trihydroxy-16,17-[(1-Methylethylidene)bis(oxy)]
pregna-1,4-diene-3,20-dione
|
161740-69-8
|
C24H31FO7
|
|
21-Methoxy Triamcinolone Acetonide
|
161740-70-1
|
C25H33FO7
|
|
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-amino-3-methyl-,(6R-trans)-(9CI)
|
161742-21-8
|
C8H12N2O2S
|
|
1H-2-Benzothiopyran-1-carbonyl chloride, 3,4-dihydro- (9CI)
|
161744-20-3
|
C10H9ClOS
|
|
15(S)-HAEA
|
161744-53-2
|
C22H37NO3
|
|
(R)-2,6-diMethyl-1,2,3,4-tetrahydroquinoline
|
161745-33-1
|
C11H15N
|
|
3,4-Dioctylthiophene
|
161746-06-1
|
C20H36S
|
|
7H-Pyrazolo[4,3-d]pyrimidin-7-one, 3,4-dihydro- (9CI)
|
161746-78-7
|
C5H4N4O
|
|
4H-Pyrazolo[3,4-d]pyrimidin-4-one, 3,5-dihydro- (9CI)
|
161746-79-8
|
C5H4N4O
|
|
1,2-Benzenedicarboxaldehyde,3-fluoro-(9CI)
|
161747-14-4
|
C8H5FO2
|
|
GLP-1 (9-36) amide (human, bovine, guinea pig, mouse, porcine, rat)
|
161748-29-4
|
C140H214N36O43
|
|
Daniplestim
|
161753-30-6
|
C564H909N161O166S5
|
|
Nsc670365
|
161753-49-7
|
C22H24O5
|
|
(S)-N-(2,2-Difluoroethylidene)-1-phenylethylamine
|
161754-60-5
|
C10H11F2N
|
|
|
Propylene oxide-dimethylsiloxane-propylene oxide block copolymer, hydroxyl terminated, viscosity 200-300 cSt.
|
161755-53-9
|
|
|
LAURETH-6 CITRATE
|
161756-30-5
|
C6H8O7.x(C2H4O)nC12H26O
|
|
Docetaxel Impurity 9
|
161759-90-6
|
C15H21NO5
|
|
2,3,4,5,6-Pentafluorophenyl 4-chlorobenzenesulphonate
|
161759-99-5
|
C12H4ClF5O3S
|
|
Tenofovir Impurity 37
|
161760-03-8
|
C10H15O6PS
|
|
Tenofovir Impurity 38
|
161760-09-4
|
C8H11O6PS
|
|
2-Benzothiazolamine,N-2-butynyl-(9CI)
|
161765-65-7
|
C11H10N2S
|
|
2-Benzothiazolamine,N-2-butynyl-5-methyl-(9CI)
|
161765-70-4
|
C12H12N2S
|
|
Ethyl 2-O-benzoyl-4,6-O-benzylidene-beta-D-galactopyranoside
|
161765-88-4
|
C22H24O7
|
|
3-(4-(Carboxypyridin-3-yl)benzoic acid
|
161767-55-1
|
C13H11NO2
|
|
3-Trimethylstannyl benzoic acid
|
161767-56-2
|
C10H14O2Sn
|
|
4-Bromo-N-isobutylbenzamide
|
161768-66-7
|
C11H14BrNO
|
|
2,5-Hexanedione, 3-hydroxy-3-methyl- (9CI)
|
161771-60-4
|
C7H12O3
|
|
PidotiMod Diketopiperazine-6-propanoic Acid
|
161771-75-1
|
C9H12N2O4S
|
|
1H,3H,5H-pyrrolo[1,2-a]thiazolo[3,4-d]pyrazine5,8,10(5aH,10aH)-trione,dihydro-
|
161771-76-2
|
C9H10N2O3S
|
|
2-Pyridin-2-yl-thiazole-4-carboxylic acid ethyl ester
|
161772-80-1
|
C11H10N2O2S
|
|
Dimethoxyapigeninidin, 5,7-(SH)
|
161773-50-8
|
C17H15ClO4
|
|
Methoxyapigeninidin chloride, 7-(RG)
|
161773-51-9
|
C16H13ClO4
|
|
AKOS B013900
|
161790-15-4
|
C10H11FO3
|
|
AKOS B013870
|
161790-21-2
|
C10H10F2O3
|
|
2-(2-Fluoro-phenoxy)-butyric acid
|
161790-23-4
|
C10H11FO3
|
|
AKOS B013886
|
161790-26-7
|
C12H16O3
|
|
2-(4-Isopropylphenoxy)butanoic acid
|
161790-36-9
|
C13H18O3
|
|
AKOS B013860
|
161790-37-0
|
C12H16O3
|
|
2-(2-Methylphenoxy)butanoic acid
|
161790-50-7
|
C11H14O3
|
|
1H-1,2,4-Triazol-3-amine,5-(3-furanyl)-(9CI)
|
161793-04-0
|
C6H6N4O
|
|
2,3,4-Trifluorobenzaldehyde
|
161793-17-5
|
C7H3F3O
|
|
Spiro[bicyclo[3.1.0]hexane-2,2-[1,3]dioxolane]-1-methanol (9CI)
|
161794-35-0
|
C9H14O3
|
|
5-tert-Butyl methylisophthalate
|
161796-10-7
|
C9H7BrO4
|
|
3-Fluoro-4-(methoxycarbonyl)benzoic acid
|
161796-11-8
|
C9H7FO4
|
|
3-Amino-4-chlorobenzoic acid methyl ester hydrochloride
|
161796-15-2
|
C8H9Cl2NO2
|
|
(R)-Omeprazole Sodium Salt
|
161796-77-6
|
C17H18N3NaO3S
|
|
Esomeprazole sodium
|
161796-78-7
|
C34H36MgN6O6S2
|
|
Esomeprazole potassium
|
161796-84-5
|
C17H19N3O3S.K
|
|
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate
|
161797-99-5
|
C13H13NO3S
|
|
Ethyl 2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate
|
161798-01-2
|
C14H13NO4S
|
|
Ethyl 2-(3-Cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
|
161798-02-3
|
C14H12N2O3S
|
|
Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate
|
161798-03-4
|
C18H21NO4S
|
|
2H-1-Benzopyran-2-one,6,7-dihydroxy-4-(hydroxymethyl)-(9CI)
|
161798-16-9
|
C10H8O5
|
|
4-(bromomethyl)-7-hydroxy-chromen-2-one
|
161798-25-0
|
C10H7BrO3
|
|
2-(4-Dimethylamino-benzylamino)-ethanol
|
161798-71-6
|
C11H18N2O
|
|
N1-(4-nitrobenzyl)propane-1,3-diamine
|
161799-74-2
|
C10H15N3O2
|
|
3-Pyrazolidinone, 1,2-diacetyl- (9CI)
|
161799-96-8
|
C7H10N2O3
|
|
1H,7H-Pyrazolo[1,2-a]pyrazole-1,7-dione, tetrahydro-2-methyl-
|
161799-98-0
|
C7H10N2O2
|
|
ETA antagonist 1
|
161801-60-1
|
C20H25N3O3S
|
|
Benzamil hydrochloride
|
161804-20-2
|
C13H15Cl2N7O
|
|
1,3-Thiazol-5-ylmethylamine
|
161805-76-1
|
C4H6N2S
|
|
tert-Butyl ((3S,4S)-1-chloro-4-methyl-2-oxohexan-3-yl)carbamate
|
161805-78-3
|
C12H22ClNO3
|
|
2-[2-(1H-indol-3-yl)ethyl]-1H-benzoimidazole
|
161806-39-9
|
C17H15N3
|
|
N-[4-(2-amino-4,5-dihydro-1,3-thiazol-4-yl)phenyl]-4-(1H-indol-3-yl)bu tanamide
|
161806-43-5
|
C21H22N4OS
|
|
(6-Chloro-pyridin-2-yl)-acetic acid methyl ester
|
161807-18-7
|
C8H8ClNO2
|
|
3-(4-Bromophenyl)-1,1,1-trifluoro-2-propanone
|
161809-64-9
|
C9H6BrF3O
|
|
Ethanone, 1-[(1R,2R,3S,4S)-3-methylbicyclo[2.2.1]hept-5-en-2-yl]- (9CI)
|
161814-11-5
|
C10H14O
|
|
Cyclopropanecarboxylic acid, 2-fluoro-, butyl ester, (1R-cis)- (9CI)
|
161814-30-8
|
C8H13FO2
|
|
AMPRENAVIR
|
161814-49-9
|
C25H35N3O6S
|